Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

HIP1 (Huntingtin Interacting Protein 1)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

ALK-HIP1 fusion	Non Small Cell Lung Cancer	ALK-HIP1 fusion	Non Small Cell Lung Cancer	alectinib Sensitive: C3 – Early Trials alectinib Sensitive : C3	alectinib Sensitive: C3 – Early Trials alectinib Sensitive : C3
ALK-HIP1 fusion	Non Small Cell Lung Cancer	ALK-HIP1 fusion	Non Small Cell Lung Cancer	crizotinib Sensitive: C3 – Early Trials crizotinib Sensitive : C3	crizotinib Sensitive: C3 – Early Trials crizotinib Sensitive : C3
ALK-HIP1 fusion	Non Small Cell Lung Cancer	ALK-HIP1 fusion	Non Small Cell Lung Cancer	ensartinib Sensitive: C3 – Early Trials ensartinib Sensitive : C3	ensartinib Sensitive: C3 – Early Trials ensartinib Sensitive : C3
HIP1-ALK I1171N	Non Small Cell Lung Cancer	HIP1-ALK I1171N	Non Small Cell Lung Cancer	crizotinib Resistant: C4 – Case Studies crizotinib Resistant : C4	crizotinib Resistant: C4 – Case Studies crizotinib Resistant : C4
HIP1-ALK I1171N	Non Small Cell Lung Cancer	HIP1-ALK I1171N	Non Small Cell Lung Cancer	alectinib Resistant: C4 – Case Studies alectinib Resistant : C4	alectinib Resistant: C4 – Case Studies alectinib Resistant : C4
ALK-HIP1 fusion	Lung Adenocarcinoma	ALK-HIP1 fusion	Lung Adenocarcinoma	alectinib Sensitive: C4 – Case Studies alectinib Sensitive : C4	alectinib Sensitive: C4 – Case Studies alectinib Sensitive : C4
LTBP1-ALK fusion + HIP1-ALK fusion	Lung Adenocarcinoma	LTBP1-ALK fusion + HIP1-ALK fusion	Lung Adenocarcinoma	alectinib Sensitive: C4 – Case Studies alectinib Sensitive : C4	alectinib Sensitive: C4 – Case Studies alectinib Sensitive : C4